SynthesisPloS one2021

The safety of nintedanib for the treatment of interstitial lung disease: A systematic review and meta-analysis of randomized controlled trials.

Chao-Hsien Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.